What do Analysts Say about Kulicke and Soffa Industries, Inc.(NASDAQ:KLIC): Abbott Laboratories(NYSE:ABT)

0
5

Kulicke and Soffa Industries, Inc. (KLIC) will report its next earnings on May 02 AMC. The company reported the earnings of $0/Share in the last quarter where the estimated EPS by analysts was $0.08/share. The difference between the expected and actual EPS was $-0.08/share, which represents an Earnings surprise of -100%.

Many analysts are providing their Estimated Earnings analysis for Kulicke and Soffa Industries, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $0.07/share. These analysts have also projected a Low Estimate of $0.03/share and a High Estimate of $0.1/share.

In case of Revenue Estimates, 4 analysts have provided their consensus Average Revenue Estimates for Kulicke and Soffa Industries, Inc. as 129.95 Million. According to these analysts, the Low Revenue Estimate for Kulicke and Soffa Industries, Inc. is 129.82 Million and the High Revenue Estimate is 130 Million. The company had Year Ago Sales of 268.83 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for KLIC to be -91%. They are projecting Next Quarter growth of -44.44%. For the next 5 years, Kulicke and Soffa Industries, Inc. is expecting Growth of 167.18% per annum, whereas in the past 5 years the growth was -73.66% per annum.

Some buy side analysts are also providing their Analysis on Kulicke and Soffa Industries, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Kulicke and Soffa Industries, Inc. might touch $30 high while the Average Price Target and Low price Target is $27.25 and $22 respectively.

Kulicke and Soffa Industries, Inc. closed its last trading session at $19.32 with the gain of 1.55%. The Market Capitalization of the company stands at 1.31 Billion. The Company has 52-week high of $28.69 and 52-week low of $17.40. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -10.27% where SMA50 and SMA200 are -13.25% and -12.73% respectively. The Company Touched its 52-Week High on 07/13/18 and 52-Week Low on 11/20/18.

The Relative Volume of the company is 1.08 and Average Volume (3 months) is 360.57 million. The company’s P/E (price to earnings) ratio is 13.23 and Forward P/E ratio of 11.08.

The company shows its Return on Assets (ROA) value of 8.1%. The Return on Equity (ROE) value stands at 10.9%. While it’s Return on Investment (ROI) value is 16.8%.

While looking at the Stock’s Performance, Kulicke and Soffa Industries, Inc. currently shows a Weekly Performance of -4.76%, where Monthly Performance is -17.8%, Quarterly performance is -15.97%, 6 Months performance is -5.94% and yearly performance percentage is -11.58%. Year to Date performance value (YTD perf) value is -3.21%. The Stock currently has a Weekly Volatility of 2.73% and Monthly Volatility of 3.36%.

Abbott Laboratories (ABT) will report its next earnings on Apr 17 BMO. The company reported the earnings of $0.63/Share in the last quarter where the estimated EPS by analysts was $0.61/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 3.3%.

Many analysts are providing their Estimated Earnings analysis for Abbott Laboratories and for the current quarter 20 analysts have projected that the stock could give an Average Earnings estimate of $0.8/share. These analysts have also projected a Low Estimate of $0.78/share and a High Estimate of $0.81/share.

In case of Revenue Estimates, 18 analysts have provided their consensus Average Revenue Estimates for Abbott Laboratories as 8 Billion. According to these analysts, the Low Revenue Estimate for Abbott Laboratories is 7.95 Billion and the High Revenue Estimate is 8.03 Billion. The company had Year Ago Sales of 7.77 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for ABT to be 9.6%. They are projecting Next Quarter growth of 13.33%. For the next 5 years, Abbott Laboratories is expecting Growth of 12.29% per annum, whereas in the past 5 years the growth was 11.81% per annum.

Some buy side analysts are also providing their Analysis on Abbott Laboratories, where 5 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Abbott Laboratories might touch $88 high while the Average Price Target and Low price Target is $83.06 and $76 respectively.

Abbott Laboratories closed its last trading session at $76.03 with the gain of 0.3%. The Market Capitalization of the company stands at 135.65 Billion. The Company has 52-week high of $80.74 and 52-week low of $60.32. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.28% where SMA50 and SMA200 are -2.06% and 5.71% respectively. The Company Touched its 52-Week High on 04/01/19 and 52-Week Low on 06/25/18.

The Relative Volume of the company is 0.56 and Average Volume (3 months) is 5.45 million. The company’s P/E (price to earnings) ratio is 51.32 and Forward P/E ratio of 21.17.

The company shows its Return on Assets (ROA) value of 3.8%. The Return on Equity (ROE) value stands at 8.5%. While it’s Return on Investment (ROI) value is 6.1%.

While looking at the Stock’s Performance, Abbott Laboratories currently shows a Weekly Performance of -0.33%, where Monthly Performance is 0.21%, Quarterly performance is 1.49%, 6 Months performance is 5.86% and yearly performance percentage is 22.78%. Year to Date performance value (YTD perf) value is 5.43%. The Stock currently has a Weekly Volatility of 1.25% and Monthly Volatility of 1.71%.

SHARE